vs
OneWater Marine Inc.（ONEW）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是OneWater Marine Inc.的1.7倍（$772.1M vs $442.3M），Revvity净利率更高（12.7% vs -2.9%，领先15.7%），Revvity同比增速更快（5.9% vs -8.5%），过去两年Revvity的营收复合增速更高（9.0% vs 8.2%）
OneWater Marine Inc.是美国头部休闲船舶零售企业，主营全新及二手船只、游艇、船舶零配件销售，同时提供船只维修保养、配套融资等服务，通过覆盖北美多州的经销商网络服务个人及商业休闲船艇客户。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
ONEW vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.7倍
$442.3M
营收增速更快
RVTY
高出14.4%
-8.5%
净利率更高
RVTY
高出15.7%
-2.9%
两年增速更快
RVTY
近两年复合增速
8.2%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $442.3M | $772.1M |
| 净利润 | $-12.9M | $98.4M |
| 毛利率 | 23.9% | — |
| 营业利润率 | 1.7% | 14.5% |
| 净利率 | -2.9% | 12.7% |
| 营收同比 | -8.5% | 5.9% |
| 净利润同比 | — | 3.9% |
| 每股收益（稀释后） | $-0.78 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ONEWRVTY
| Q2 26 | $442.3M | — | ||
| Q1 26 | $380.6M | — | ||
| Q4 25 | $380.6M | $772.1M | ||
| Q3 25 | $460.1M | $698.9M | ||
| Q2 25 | $552.9M | $720.3M | ||
| Q1 25 | $483.5M | $664.8M | ||
| Q4 24 | $375.8M | $729.4M | ||
| Q3 24 | $377.9M | $684.0M |
净利润ONEWRVTY
| Q2 26 | $-12.9M | — | ||
| Q1 26 | $-7.7M | — | ||
| Q4 25 | $-7.7M | $98.4M | ||
| Q3 25 | $-113.0M | $46.7M | ||
| Q2 25 | $10.7M | $53.9M | ||
| Q1 25 | $-368.0K | $42.2M | ||
| Q4 24 | $-12.0M | $94.6M | ||
| Q3 24 | $-9.2M | $94.4M |
毛利率ONEWRVTY
| Q2 26 | 23.9% | — | ||
| Q1 26 | 23.5% | — | ||
| Q4 25 | 23.5% | — | ||
| Q3 25 | 22.6% | 53.6% | ||
| Q2 25 | 23.3% | 54.5% | ||
| Q1 25 | 22.8% | 56.5% | ||
| Q4 24 | 22.4% | — | ||
| Q3 24 | 24.0% | 56.3% |
营业利润率ONEWRVTY
| Q2 26 | 1.7% | — | ||
| Q1 26 | — | — | ||
| Q4 25 | -1.4% | 14.5% | ||
| Q3 25 | -28.3% | 11.7% | ||
| Q2 25 | 5.5% | 12.6% | ||
| Q1 25 | 3.4% | 10.9% | ||
| Q4 24 | -0.5% | 16.3% | ||
| Q3 24 | 1.2% | 14.3% |
净利率ONEWRVTY
| Q2 26 | -2.9% | — | ||
| Q1 26 | -2.0% | — | ||
| Q4 25 | -2.0% | 12.7% | ||
| Q3 25 | -24.5% | 6.7% | ||
| Q2 25 | 1.9% | 7.5% | ||
| Q1 25 | -0.1% | 6.4% | ||
| Q4 24 | -3.2% | 13.0% | ||
| Q3 24 | -2.4% | 13.8% |
每股收益（稀释后）ONEWRVTY
| Q2 26 | $-0.78 | — | ||
| Q1 26 | $-0.47 | — | ||
| Q4 25 | — | $0.86 | ||
| Q3 25 | — | $0.40 | ||
| Q2 25 | — | $0.46 | ||
| Q1 25 | — | $0.35 | ||
| Q4 24 | — | $0.77 | ||
| Q3 24 | — | $0.77 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $269.4M | $7.3B |
| 总资产 | $1.4B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ONEWRVTY
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | $919.9M | ||
| Q3 25 | — | $931.4M | ||
| Q2 25 | — | $991.8M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | $1.2B |
股东权益ONEWRVTY
| Q2 26 | $269.4M | — | ||
| Q1 26 | $277.5M | — | ||
| Q4 25 | $277.5M | $7.3B | ||
| Q3 25 | $285.0M | $7.4B | ||
| Q2 25 | $393.2M | $7.6B | ||
| Q1 25 | $381.6M | $7.6B | ||
| Q4 24 | $354.8M | $7.7B | ||
| Q3 24 | $360.8M | $7.9B |
总资产ONEWRVTY
| Q2 26 | $1.4B | — | ||
| Q1 26 | $1.4B | — | ||
| Q4 25 | $1.4B | $12.2B | ||
| Q3 25 | $1.4B | $12.1B | ||
| Q2 25 | $1.5B | $12.4B | ||
| Q1 25 | $1.6B | $12.4B | ||
| Q4 24 | $1.6B | $12.4B | ||
| Q3 24 | $1.6B | $12.8B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $182.0M |
| 自由现金流经营现金流 - 资本支出 | — | $161.8M |
| 自由现金流率自由现金流/营收 | — | 21.0% |
| 资本支出强度资本支出/营收 | — | 2.6% |
| 现金转化率经营现金流/净利润 | — | 1.85× |
| 过去12个月自由现金流最近4个季度 | — | $509.4M |
8季度趋势，按日历期对齐
经营现金流ONEWRVTY
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $-76.3M | $182.0M | ||
| Q3 25 | $9.9M | $138.5M | ||
| Q2 25 | $90.8M | $134.3M | ||
| Q1 25 | $28.5M | $128.2M | ||
| Q4 24 | $-37.4M | $174.2M | ||
| Q3 24 | $27.3M | $147.9M |
自由现金流ONEWRVTY
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $-78.2M | $161.8M | ||
| Q3 25 | $7.2M | $120.0M | ||
| Q2 25 | $88.9M | $115.5M | ||
| Q1 25 | $23.7M | $112.2M | ||
| Q4 24 | $-40.0M | $149.8M | ||
| Q3 24 | $23.2M | $125.6M |
自由现金流率ONEWRVTY
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | -20.6% | 21.0% | ||
| Q3 25 | 1.6% | 17.2% | ||
| Q2 25 | 16.1% | 16.0% | ||
| Q1 25 | 4.9% | 16.9% | ||
| Q4 24 | -10.7% | 20.5% | ||
| Q3 24 | 6.1% | 18.4% |
资本支出强度ONEWRVTY
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | 2.6% | ||
| Q3 25 | 0.6% | 2.6% | ||
| Q2 25 | 0.4% | 2.6% | ||
| Q1 25 | 1.0% | 2.4% | ||
| Q4 24 | 0.7% | 3.4% | ||
| Q3 24 | 1.1% | 3.3% |
现金转化率ONEWRVTY
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | 1.85× | ||
| Q3 25 | — | 2.97× | ||
| Q2 25 | 8.47× | 2.49× | ||
| Q1 25 | — | 3.03× | ||
| Q4 24 | — | 1.84× | ||
| Q3 24 | — | 1.57× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ONEW
| New boat | $272.0M | 62% |
| Pre-owned boat | $94.4M | 21% |
| Service, parts & other | $61.9M | 14% |
| Finance & insurance income | $14.0M | 3% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
